Filter
114
Featured
Language
Document type
No document type
66
Guidelines
16
Manuals
9
Fact sheets
9
Studies & Reports
6
Strategic & Response Plan
3
Training Material
2
Situation Updates
1
Online Courses
1
Videos
1
Countries / Regions
Russia
4
India
3
El Salvador
3
Colombia
2
Ecuador
2
Eastern Europe
2
Global
2
Uganda
1
Kenya
1
Peru
1
Ukraine
1
Chile
1
Latin America and the Carribbean
1
Western and Central Europe
1
Asia
1
Africa
1
Albania
1
Armenia
1
Tajikistan
1
Moldova
1
Authors & Publishers
World Health Organization WHO
20
World Health Organization
16
International Union Against Tuberculosis and Lung Disease
7
et al.
5
World Health Organisation (WHO)
5
Alabí Montoya, F.J.
3
Ministerio de Salud El Salvador
3
Organisation mondiale de la Santé
3
The Union
3
WHO
3
challenge TB
2
International Union Against Tuberculosis and Lung Disease, World Health Organization
2
Organización Mundial de la Salud OMS
2
R. Gie
2
Stop TB Partnership
2
World Health Organization WHO, Regional Office of Europe
2
A. Pawlowski, M. Jansson, M. Sköld, et al.
1
AIDSinfo
1
Alberto Piubello
1
Alliance for Public Health
1
and S. Mauder
1
BC Centre for Disease Control
1
Bundesinstitut für Arzneimittel und Mediziprodukte
1
CDC United States
1
Centers for Disease Control and Prevention
1
Centers for Disease Control and Prevention CDC
1
Centers for Disease Control and Prevention, National Center for HIV
1
Cochrane
1
D. Falzon, USAID, Asia Regional Pharmacovigilance
1
D. Sculier
1
Dr. Стивена Грэхема, Dr. Малгосии Грземска, Dr. Сюзанны Хилл et al.
1
El Fondo Mundial
1
Erika Duffell, Igor Toskin
1
et. al
1
European Medicines Agency
1
G. Franco-Sotomayor
1
G. K. Siberry
1
G. Williams, E. Alarcón, S. Jittimanee et al.
1
Global Laboratory Initiative
1
González Sanjuan, S.
1
GP clinics
1
Graham, S.M.et al.
1
H. Getahun
1
H. L. Rieder, A. Van Deun, K. M. Kam, et. al
1
H. Schünemann, S.T. Aung, F. Bonsu et al.
1
Haut Conseil de la Santé Publique
1
Hidalgo, R.
1
International Union Against Tuberculosis and Lung Disease (The Union)
1
J.
1
J. A. Caminero, A. Van Deun, P. I. Fujiwara, et. al
1
José A. Caminero
1
K. Ciceri
1
Kasmera
1
Khairunisa Suleiman
1
KNCV
1
L. N. Patel,and A. K. Detjen
1
L.A. Chimoy and C. Tunoque
1
Le Fonds Mondial
1
Lesley Odendal
1
Lin, Y., et al.
1
M. B. Ruíz
1
M. J. Abzug
1
M. Ramos-Ramirez
1
Madhukar Pai
1
Medecins Sans Frontiers
1
Medical Research Council Clinical Trials Unit (MRC CTU) at UCL
1
Mèdecines sans Frontières MSF
1
Médecins sans Frontières MSF
1
Ministerio de Salud Chile
1
Ministerio de Salud Ecuador
1
Ministerio de Salud y Proteccion Social Bogota, Colombia
1
National Tuberculosis Center, New Jersey Medical School
1
O. Smetanina
1
Organizaición Mundial de la Salud
1
Organizaición Mundial de la Salud (OMS)
1
Ortiz-Jiménez
1
P. I. Fujiwara, R. A. Dlodlo, O. Ferroussier, et. al
1
Pan American Health Organisation PAHO
1
PepFar
1
PLOS Phatogens
1
Puibello, A.
1
Reijer, P.
1
Republic of Kenya, Ministry of Health
1
Richard Lumb, Armand Van Deun, Ivan Bastian, Mark Fitz-Gerald
1
S. Nachman et al.
1
Sánchez Sánchez, Y.
1
SHINE
1
Stephen M. Graham
1
Stop TB
1
Stop TB Parntership
1
T. Frieden
1
TB Alliance
1
The Global Fund
1
The International Union Against Tuberculosis and Lung Disease
1
Treatment Action Group
1
Tuberculosis Coalition for Technical Assistance (TBCTA), USAID
1
Union Internationale Contre la Tuberculose et les Maladies Respiratoires
1
Unión Internacional Contra la tuberculosis y Enfermedades Respirations
1
Unión Internacional Contra la Tuberculosis y Enfermedades Respiratorias
1
Unitaid
1
UNITAID, WHO, Global Laboratory Initiative, et. al
1
USAID, l'Union, Initiative 5%
1
USAID, TB Care, SA Pathology
1
World Health Organisation
1
World Health Organization (Europe)
1
World Health Organization, National Tuberculosis Center
1
Zifodaya, J.
1
Глобальный фонд
1
Глобальный фонд для борьбы со СПИДом, туберкулезом и малярией
1
Департамент "Остановить туберкулез", ВОЗ
1
Ниша Ахамед, Елена Юрасова, Ричард Залексис
1
нтон Харрис, Дермот Махер, Стивен Грэхем et al.
1
Publication Years
Category
Clinical Guidelines
34
Countries
13
Pharmacy & Technologies
8
Women & Child Health
1
Key Resources
1
Addressing comorbidities and risk factors for tuberculosis (TB) is a crucial component of the World Health Organization (WHO)’s End TB Strategy. This WHO operational handbook on tuberculosis. Module 6: tuberculosis and comorbidities aims to support countries in scaling up people-centred care, ... more
Objective To assess the effectiveness of a community-based tuberculosis and leprosy intervention in which village health teams and health workers conduct door-to-door tuberculosis screening, targeted screenings and contact tracing.
The Roadmap towards ending TB among children and adolescents, third edition builds on the 2013 and 2018 versions. The 2023 version recognizes the progress made over the past five years and outlines priorities and key actions designed to accelerate progress towards the targets elaborated during the 2 ... more
This document provides practical guidance on planning and implementing next-generation sequencing (NGS) technology for characterization of Mycobacterium tuberculosis complex (MTBC) bacteria. The aim is to detect mutations associated with drug resistance in the context of a surveillance system for tu ... more
The WHO standard: Universal access to rapid tuberculosis diagnostics sets benchmarks to achieve universal access to WHO-recommended rapid diagnostics (WRDs), increase bacteriologically confirmed tuberculosis and drug resistance detection, and reduce the time to diagnosis. WHO-recommended rapid diagn ... more
Tuberculosis (TB) is the deadliest infectious disease in most low- and middle-income countries, claiming more than 4,000 lives each day. The unprecedented COVID-19 pandemic has seriously impacted people with pre-existing health conditions. People with TB are usually more vulnerable to other infectio ... more
Following review of evidence and advice from the Technical Advisory Group (TAG) on Tuberculosis (TB) Diagnostics and Laboratory Strengthening, the World Health Organization (WHO) announces that current WHO recommendations for the use of interferon-gamma release assays (IGRA) are also valid for Beij ... more
GDF is the largest global provider of quality-assured tuberculosis (TB) medicines, diagnostics, and laboratory supplies to the public sector. Since 2001, GDF has facilitated access to high-quality TB care in over 130 countries, providing treatments to over 30 million people with TB and procuring ... more
This Tuberculosis guide has been developed jointly by Médecins Sans Frontières and Partners In Health. It aims at providing useful information to the clinicians and health staff for the comprehensive management of tuberculosis. Forms of susceptible and resistant tuberculosis, tuberculosis in child ... more
This Tuberculosis guide has been developed jointly by Médecins Sans Frontières and Partners In Health. It aims at providing useful information to the clinicians and health staff for the comprehensive management of tuberculosis. Forms of susceptible and resistant tuberculosis, tuberculosis in child ... more
MEDBOX Issue Brief no. 19: World TB Day: Invest to end TB. Save Lives
Las recomendaciones contenidas en este módulo son un componente de las directrices unificadas de la OMS sobre la tuberculosis (TB) y están destinadas principalmente para el uso de los programas nacionales de control de la tuberculosis, los organismos de salud pública y otros interesados clave que ... more
The practical guidance in the operational handbook aims to inform the development or revision of national policies and related implementation guidance on the management of TB in children and adolescents under programmatic circumstances and at different levels of the health system. The operational ha ... more
The Updated guidelines on Management of tuberculosis in children and adolescents include new recommendations that cover diagnostic approaches for TB, shorter treatment for children with non-severe drug-susceptible TB, a new option for the treatment of TB meningitis, the use of bedaquiline and delama ... more

Shorter treatment for children with minimal TB

SHINE Medical Research Council Clinical Trials Unit (MRC CTU) at UCL (2022) CC
The results of the SHINE trial have been published in the NEJM today. SHINE looked at whether treatment for children with minimal TB could be reduced from 6 months to 4 months. It found that the four month treatment was as good as the standard six months treatment for children with minimal TB
The consolidated guidelines are complemented by an operational handbook which is designed to assist with implementation of the WHO recommendations by Member States, technical partners and others who are involved in the management of patients with DR-TB. The WHO Operational Handbook on Tuberculosis, ... more
LAM test as a diagnostic aid in patients with HIV and suspected tuberculosis: technical guidelines
6 July 2021. The “WHO consolidated guidelines on tuberculosis. Module 3: Diagnosis - Rapid diagnostics for tuberculosis detection 2021 update” is the latest document replacing the one issued in 2020. Three new nucleic acid amplification test (NAAT) classes are endorsed by WHO and included in the ... more